Fibromatosis-like metaplastic carcinoma: a case report and review of the literature.


Journal

Diagnostic pathology
ISSN: 1746-1596
Titre abrégé: Diagn Pathol
Pays: England
ID NLM: 101251558

Informations de publication

Date de publication:
03 Mar 2020
Historique:
received: 04 12 2019
accepted: 26 02 2020
entrez: 5 3 2020
pubmed: 5 3 2020
medline: 26 11 2020
Statut: epublish

Résumé

We report an unusual case of low-grade fibromatosis-like metaplastic carcinoma (LG-FLMC) of the breast. This exceedingly rare epithelial breast malignancy has been reported only 68 times in the past 20 years, and is classified as a subtype of metaplastic breast carcinoma (MBC). It is a locally aggressive tumor with a low potential for lymph node and distant metastases, but with a tendency to recur after excision. Here we describe a less common presentation of LG-FLMC, provide its molecular characterization, discuss the major differential diagnosis and bring a short review of the literature. A 65-year-old woman presented with a self-palpated breast lump that had discordant radio-pathological features. While imaging results were compatible with an infiltrative malignancy, on core needle biopsy (CNB) a sharply delineated lesion composed by a bland-looking population of spindle cells was observed; excision was recommended for final diagnosis. Histology of the resection specimen showed small areas of epithelial differentiation and foci of peripheral invasion. Immunohistochemical analysis revealed a co-immunoreactivity for epithelial and myoepithelial markers in the spindle cell component. Mutation analysis with a capture-based next generation sequencing method revealed pathogenic mutations in GNAS, TERT-promotor and PIK3R1 genes. A diagnosis of LG-FLMC was rendered. This case highlights the importance of a broad differential diagnosis, exhaustive sampling and the use of a broad immunohistochemical panel whenever dealing with a low-grade spindle cell lesion in the breast, and provides further insights into the molecular background of LG-FLMC.

Sections du résumé

BACKGROUND BACKGROUND
We report an unusual case of low-grade fibromatosis-like metaplastic carcinoma (LG-FLMC) of the breast. This exceedingly rare epithelial breast malignancy has been reported only 68 times in the past 20 years, and is classified as a subtype of metaplastic breast carcinoma (MBC). It is a locally aggressive tumor with a low potential for lymph node and distant metastases, but with a tendency to recur after excision. Here we describe a less common presentation of LG-FLMC, provide its molecular characterization, discuss the major differential diagnosis and bring a short review of the literature.
CASE PRESENTATION METHODS
A 65-year-old woman presented with a self-palpated breast lump that had discordant radio-pathological features. While imaging results were compatible with an infiltrative malignancy, on core needle biopsy (CNB) a sharply delineated lesion composed by a bland-looking population of spindle cells was observed; excision was recommended for final diagnosis. Histology of the resection specimen showed small areas of epithelial differentiation and foci of peripheral invasion. Immunohistochemical analysis revealed a co-immunoreactivity for epithelial and myoepithelial markers in the spindle cell component. Mutation analysis with a capture-based next generation sequencing method revealed pathogenic mutations in GNAS, TERT-promotor and PIK3R1 genes. A diagnosis of LG-FLMC was rendered.
CONCLUSION CONCLUSIONS
This case highlights the importance of a broad differential diagnosis, exhaustive sampling and the use of a broad immunohistochemical panel whenever dealing with a low-grade spindle cell lesion in the breast, and provides further insights into the molecular background of LG-FLMC.

Identifiants

pubmed: 32127014
doi: 10.1186/s13000-020-00943-x
pii: 10.1186/s13000-020-00943-x
pmc: PMC7053053
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

20

Références

Histopathology. 2016 Jan;68(1):33-44
pubmed: 26768028
Arch Pathol Lab Med. 2006 May;130(5):e81-3
pubmed: 16683904
World J Surg Oncol. 2007 Feb 27;5:24
pubmed: 17324295
Clin Breast Cancer. 2012 Apr;12(2):147-50
pubmed: 22444721
Int J Clin Exp Pathol. 2018 Jul 01;11(7):3691-3696
pubmed: 31949751
J Clin Pathol. 2015 May;68(5):362-7
pubmed: 25713418
Mod Pathol. 2018 Nov;31(11):1661-1674
pubmed: 29946183
Cancer. 1999 May 15;85(10):2170-82
pubmed: 10326695
Tumori. 2009 Mar-Apr;95(2):264-7
pubmed: 19579879
Histopathology. 2018 Aug;73(2):273-283
pubmed: 29537649
Cesk Patol. 2002 Oct;38(4):164-8
pubmed: 12629863
Nat Commun. 2018 May 8;9(1):1816
pubmed: 29739933
Am J Pathol. 2017 Oct;187(10):2139-2151
pubmed: 28736315
Mod Pathol. 2010 Nov;23(11):1438-48
pubmed: 20693983
Nat Med. 2017 Jun;23(6):703-713
pubmed: 28481359
Clin Cancer Res. 2017 Jul 15;23(14):3859-3870
pubmed: 28153863
J Pathol. 2018 Jul;245(3):373-383
pubmed: 29708279
Am J Surg Pathol. 2001 Aug;25(8):1009-16
pubmed: 11474284
Arch Pathol Lab Med. 2015 Apr;139(4):552-7
pubmed: 25822766
Appl Immunohistochem Mol Morphol. 2018 Oct;26(9):648-653
pubmed: 28027119
Semin Diagn Pathol. 2017 Sep;34(5):400-409
pubmed: 28629810
Mod Pathol. 2019 Mar;32(Suppl 2):1-178
pubmed: 30886301

Auteurs

Jasper Victoor (J)

Department of Pathology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. jasper.victoor@uzleuven.be.

Claire Bourgain (C)

Department of Pathology, Imelda hospital, Bonheiden, Belgium.

Sara Vander Borght (S)

Department of Pathology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.
Department of Human Genetics, University Hospitals Leuven, Leuven, Belgium.

Isabelle Vanden Bempt (I)

Department of Human Genetics, University Hospitals Leuven, Leuven, Belgium.

Carine De Rop (C)

Department of Gynecology, Imelda hospital, Bonheiden, Belgium.

Giuseppe Floris (G)

Department of Pathology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.
Laboratory of Translational Cell & Tissue Research, Department of Imaging and Pathology, KU Leuven - University of Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH